of mammalian organisms. It plays a key role in lactation and contributes to a wide range of physiological functions (1) . In the rat, PRL is secreted in various patterns depending on the physiological state of the animal. Pronounced PRL release is initiated in cycling rats during the afternoon of proestrus every fourth or fifth day or by nursing pups on lactating dams. Stimulation of the uterine cervix (CS) during mating (leading to pregnancy/pseudopregnancy) induces a PRL secretory pattern consisting of nocturnal surges (N) between 0100 and 0500 h, and diurnal surges (D) between 1600 and 1800 h (1) .
PRL is synthesized and secreted by lactotrophs in the anterior lobe of the pituitary gland (1) . Its release is under tonic inhibition by dopamine (DA) (2) , originating from three distinct hypothalamic neuronal populations (3) . It has been shown that coincident with the release of PRL, DA levels in the portal blood that supplies the anterior lobe is reduced (4, 5) . However, the temporary reduction of the PRL-inhibiting hormone (PIH) DA does not fully account for the entire amount of PRL released. Additional PRL-releasing neurohormones (PRH) of hypothalamic origin may be involved in the formation of the surges (1) . Oxytocin (OT) is one promising PRH candidate. Several in vivo and in vitro studies have indicated a stimulatory effect of OT on the release of PRL (1, 6, 7) . The infusion of OT antagonist also suppressed both the N and D PRL surges of CS rats (8) . Furthermore, in situ hybridization studies have shown OT receptor mRNA expression in lactotrophs (9) .
Neurons in the paraventricular nucleus (PVN) of the hypothalamus are major production sites for OT (10) . It has been shown that OT neurons in PVN of OVX rats display daily activity rhythms that correlate with the PRL-releasing pattern in CS rats (11) .
The suprachiasmatic nucleus (SCN) of the hypothalamus is known for its pacemaker function, responsible for timing circadian rhythms in mammals (12) . The nucleus can be subdivided into a shell and core region; the core dominated by vasoactive intestinal polypeptide (VIP)-producing neurons (13) . Neuronal tract-tracing studies demonstrated efferent connections from SCN to PVN in rats (14) . Further studies identify these efferents as VIPergic, innervating several regions of the hypothalamus (15) and in situ hybridization studies have verified VIP2 receptor mRNA expression within the PVN (16) . Immunocytochemical investigations and mRNA measurements in the SCN revealed a daily rhythm of VIP that peaks during the dark phase (17) (18) (19) . This rhythm is absent under constant dark conditions (19) and is reduced in unilaterally enucleated rats (20) .
We hypothesize that OT acts as a PRH in CS rats. In our model, the SCN serves as a pacemaker, dictating the activity pattern of hypothalamic DA and OT neurons via its rhythmic VIP output. We illustrate this hypothesis with a mathematical model that demonstrates how VIPergic control of DA and OT neurons may produce the characteristic PRL secretory pattern in CS rats.
Materials and Methods Animals
Adult female Sprague Dawley rats (Charles River, Raleigh, NC; 200 -250 g) were kept in standard rat cages under a 12-h light, 12-h dark cycle (lights on at 0600 h) with water and rat chow ad libitum. All animals were bilaterally ovariectomized (OVX) under Halothane anesthesia. The uterine cervix was electrically stimulated with two platinum electrodes placed 2 mm apart at the tip of a Teflon rod. The first CS was applied 30 h (at 1700 h) and the second 15 h (at 0900 h) before the first blood sampling time. Stimulations were applied as two consecutive trains of electric current of 10-sec duration (rectangular pulses 1 msec of 40 V at 200 Hz). This procedure has been shown to yield the highest success rate in initiating two daily PRL surges characteristic of pregnant/pseudopregnant rats (21) . All animal procedures were approved by the Florida State University Animal Care and Use Committee.
SCN guide cannula and jugular vein catheter implantation
Rats were anesthetized with a mixture of Ketamine (65 mg/kg) and Xylazine (4 mg/kg) and placed in a stereotaxic frame. After drilling a hole through the skull, bilateral stainless steel guide cannulae (26 gauge, 1 mm apart; Plastics One, Roanoke VA) were lowered to the dorsal border of the SCN (coordinates according to the rat atlas by Paxinos and Watson (22) : 0.7 mm caudal to Bregma and 7.9 mm ventral to the dura mater). The cannulae were held in place by dental cement anchored by screws.
Polyurethane catheter tubing (Micro-Renathane, Braintree Scientific Inc., Braintree, MA), extended with Tygon tubing (TGY-040-100, Small Parts Inc., Miami Lakes, FL), was inserted into the jugular vein while the rats were anesthetized with Halothane. The tubing, filled with heparinized saline (50 U/ml), was fitted sc and exteriorized at the back of the animal's neck. A daily flush with heparinized saline kept the line open until the start of the blood collection at 2300 h, 5 d after surgery.
RIA
Serum concentrations of PRL were estimated in duplicate by the rat PRL RIA kit as previously described (23) . Rat PRL RP-3 standard was supplied by Dr. Albert Parlow through the National Hormone and Pituitary Program (Torrance, CA). The measurement of serum OT concentration was performed with the Phoenix OT kit (Phoenix Pharmaceuticals Inc., Belmont, CA, validated for the use of rat serum) according to the manufacturer's protocol. The assay sensitivity was 1 pg/ml serum.
VIP antisense (AS) oligonucleotide injections
Phosphorothioated oligodeoxynucleotides (ODNs) dissolved in artificial cerebrospinal fluid (aCSF) were infused through 33-gauge needles inserted in the guide cannulae. The AS-ODNs were 20 oligomers complementary to the cap site (5Ј-GCTCTGCACTACAACCTGAC-3Ј) and translation start site (5Ј-TTGCTTCTGGATTCCATCTC-3Ј) of the rat VIP mRNA. Control random sequence (RS)-ODNs were 20 oligomers with the same ATGC content as the AS-oligos but in RS that had no significant homology to any known peptides localized in the SCN (24) . Each side of the SCN received a 0.4-l injection (applied within 1 min) of the corresponding ODN (ODN: 1 g/l in 0.9% saline solution; aCSF: 125 mm NaCl, 2.5 mm KCl, 1.25 mm NaH 2 PO 4 , 1 mm MgCl 2 , 25 mm NaHCO 3 , 2 mm CaCl 2 , 25 mm glucose), 36 h before the first blood collection time point. This dose has been previously reported not to result in significant side effects or toxicity when used for SCN injection (24) . ODN were produced locally at the Florida State University Biochemical Analysis and Synthesis Service laboratory.
Blood collection
Starting at 2300 h 5 d after surgery, 200 l of blood were collected at 2-h intervals over a period of 24 h (excluding the 0900 h time point). Serum samples were stored at 4 C until analysis.
Immunocytochemistry (ICC)
Rats were transcardially perfused with 60 ml of cold perfusion rinse (0.5% NaNO 2 in 0.9% saline solution) followed by 300 ml of cold 4% paraformaldehyde in 0.1 m PBS (pH 7.2). The brains were removed, postfixed in 4% paraformaldehyde/PBS overnight, and placed in 20% sucrose/PBS for at least 12 h. Coronal sections (40 m) of the brains (through SCN and PVN) were cut on a freezing microtome and stored in cryoprotectant (25) . Before the incubation with the primary antibody (for 24 h at 4 C), the sections were washed three times in 0.1% Triton X-100 in PBS and exposed to 10% normal goat serum (Chemicon, Temecula, CA) in PBS for 1 h. Depending on the experiment, the following primary antibody combinations were used: 1) OT (rabbit anti-OT, IHC8152, Peninsula Laboratories, Inc., Belmont, CA; dilution 1:5000); 2) OT and VIP receptor subtype 2 (mouse anti-VIP2R, AS69-P, Antibody Solutions, Palo Alto, CA; dilution 1:600) together or 3) VIP (sheep anti-VIP, AB 1581, Chemicon International Inc.; dilution 1:5000). The binding specificity of the antibodies were published in a previous study (26) . To test for specificity of label in our ICC protocol, tissue sections were incubated in antibody against VIP2R that had been preabsorbed with the immunizing VIP2R peptide (corresponding to amino acids 105-122; Antibody Solutions), whereas other sections were incubated in buffer without primary antibody. Secondary antibodies, conjugated to fluorescent probes CY2 (donkey antirabbit/sheep, Jackson ImmunoResearch, West Grove, PA) or CY3 (donkey antigoat/mouse, Jackson ImmunoResearch), were added in the concentration of 1:600 for another 24 h at 4 C. All primary and secondary antibodies were diluted in 0.4% Triton X-100/0.01% Na-Azide in PBS. Finally, sections were mounted on glass slides, coverslips applied with Aqua Polymount (Polysciences, Inc., Warrington, PA), and sealed with nail polish.
For the quantification of protein expression levels after the VIP AS-ODN injection, three 40 m-thick coronal brain sections through the ventrolateral SCN (13) were analyzed per animal for the intensity of VIP immunoreactivity as described by Turgeon et al. (27) and Gerhold et al. (24) . Two images were taken by a digital camera (SPOT camera, Diagnostic Instruments Inc., Sterling Heights, MI) per brain section (right and left core region of SCN) on a fluorescent microscope (Leica, Wetzlar, Germany). Using the image analysis software MetaMorph (version 5.0r1, Universal Imaging Corp., Downingtown, PA), the mean pixel intensity of staining was calculated (relative intensity units) within a circle (d ϭ 400 m, Fig. 4A ) encompassing the core region of SCN. The bases for the calculation were 8-bit monochrome images with a range of 255 gray values. At the end, one average number of mean ICC VIP staining intensity in the SCN was calculated per animal.
Fluoro-Gold (FG) and OT double labeling
The systemic administration of FG (Fluorochrome, LLC, Denver, CO) is a well-established method for labeling neurosecretory cells (28 -30) . In our experiments, the rats (n ϭ 3) received an injection of 20 mg/kg body weight FG, dissolved in 0.9% saline, via the tail vein. After 72 h, the same procedure as described above was used for fixing, cutting, and ICC OT labeling.
Dispersion of AP glands and lactotroph enrichment
The dispersion of AP glands was similar to our previous published protocol (31) . Before plating, the cell suspension was enriched for lactotrophs using a slightly modified version of the Percoll discontinuous density gradient enrichment protocol (32), yielding 75-90% lactotrophs. Briefly, the suspension was applied on top of a Percoll (Sigma, St. Louis, MO) density gradient [50% and 35% Percoll in HEPES-buffered saline (HBS)]. After 20 min of centrifugation (700 G), the interface was gently aspirated and transferred into HBS. After rinses in HBS and centrifugation (two times), cells were plated on 35-mm poly-l-lysine (Sigma)-coated glass coverslips in a density of 10 6 cells/coverslip and stored in 10% fetal bovine serum (FBS, Intergen, Purchase, NY)/DMEM (Invitrogen Life Technologies, Rockville, MD). The cultures were kept in a CO 2 incubator at 5% CO 2 and 37 C for 2 d before use in Ca 2ϩ imaging studies. Lactotrophs express TRH receptors (33) and release PRL in response to TRH in a dose-dependent manner (1) . Furthermore, the calcium-mobilizing actions of TRH on lactotrophs have been well characterized (34) . Therefore, lactotrophs were further identified by their post hoc response to TRH application as well as their cell type-specific morphology.
Intracellular Ca 2ϩ recordings
Intracellular Ca 2ϩ ([Ca 2ϩ ] i ) was determined by quantitative fluorescent microscopy using the calcium probe Fura-2/AM (Molecular Probes, Eugene, OR) as described previously (35) . In brief, after three HBS washes, the coverslips bearing cultured lactotrophs were incubated with 5 m Fura-2/AM in HBS for 30 min at 37 C in a CO 2 incubator before placement in a Dvorak-Stotler chamber. Average intensities of light emission of each cell were measured at 510 nm by a digital camera (C4745-95, Hamamatsu Corp., Bridgewater, NJ) during exposure to alternating 340 nm and 380 nm light beams on an inverted microscope (Axiovert 35, Zeiss, Heidelberg, Germany). Intracellular Ca 2ϩ is expressed as the ratio of 340 nm/380 nm of single cells that was calculated with the software MetaFluor (version 4.6r9, Universal Imaging Corp.). Lactotrophs were perfused with prewarmed HBS supplemented with CaCl 2 (2 mm) and MgCl 2 (1 mm) at a rate of 1 ml/min. Temperature was held constant at 37 C by an in-line solution heater (SH-27A, Warner Instruments, Inc., Hamden, CT). After establishing basal condition, test substances were applied for 2 min by switching to a perfusion solution containing OT (10 Ϫ8 -10 Ϫ6 m, Peninsula Laboratories, Inc.) or TRH (10 Ϫ6 m). The effluent media were collected every minute by a fraction collector (FC 203, Gilson Inc., Middleton, WI) and stored at 4 C until PRL concentration was determined.
Data analysis and statistics
Fluorecent labeling in brain sections was visualized using the CY2-CY3 filter combination on a fluorescent microscope (Leica) and images produced with a digital camera (SPOT camera, Diagnostic Instruments Inc.). High resolution images of OT and VIP2R immunostained brain sections were taken with a confocal laser-scanning microscope (Zeiss LSM 510), equipped with Argon/2 (488 nm) and HeNe1 (543 nm) laser light sources. Images were acquired as a Z-series stack at 0.3 m steps by using a ϫ40 Plan Neofluar 1.3NA oil objective lens in multitracking configuration. Depending on the region of interest, stacks of 20 -60 optical sections (thickness of 0.9 m) were taken from the specimens. Statistical analysis was performed using Microsoft Excel or GraphPad Prism 3.0 (GraphPad Software Inc., San Diego, CA). Significance was determined using one-way ANOVA and differences were considered significant if P Յ 0.05.
Modeling
Mathematical modeling was performed to help interpret the experimental data. The model consists of a set of three equations describing the time-dependent variation of PRL, DA, and OT concentrations. The equations reflect the stimulatory and inhibitory interactions among cell types, based on data reported in this study, as well as data from the literature. The first equation, for PRL, is
The factor 1/(k D ϩ DA) is a decreasing function of DA concentration and reflects the inhibitory effect of DA on PRL secretion. The factor
is an increasing sigmoidal function of OT concentration and reflects the stimulatory effect of OT. The final term, q P PRL, accounts for removal of PRL from the system. The second differential equation in the model describes the dynamics of DA,
The parameter DA ϱ is the steady-state or long-term value of the DA concentration. The term q D (DA ϱ Ϫ DA) ensures that DA approaches its steady-state with a time constant of 1/q D . The second term, D , is set to a positive value during periods when there is inhibitory VIP input to DA neurons from the SCN (2 h at night in the simulation of VIP RS-ODNtreated animals). This causes DA concentration to decrease.
The third differential equation describes the dynamics of OT,
The first term
is an increasing function of the stimulatory factor x. The existence of such a factor is one of the predictions of the model. This is elevated twice per day in our simulations, at night and in the afternoon. The second term, q O OT, reflects removal of OT from the system. The final term, O , is a parameter that is elevated once per day (2 h at night in simulations of VIP RS-ODN animals) and reflects inhibitory VIP input onto OT cells. Parameter values were adjusted to match the experimental PRL and OT time courses. Model equations were integrated using the CVODE numerical method as implemented in the program XPPAUT (36) . Parameter values used in the integration are listed in Table 1 . The model can be downloaded from our web site at www.neuro.fsu.edu/postDocs/egli or www.math.fsu.edu/ϳbertram.
Results

OT stimulates PRL secretion in lactotrophs through a calcium-dependent mechanism
To confirm that OT is a potent PRH, we investigated the response of lactotrophs to the application of OT by simultaneously monitoring fluctuations of [Ca 2ϩ ] i and PRL secretion in the perfusion media. For comparison, the PRL secretory response of lactotrophs to the application of TRH (10 Ϫ6 m) 10 min after the OT challenge served as a reference (regarded as 100% response) (37) .
Measurement of the concentration of PRL in effluent media from the recording chamber holding a coverslip with 10 6 cells, revealed a bell-shaped pattern (Fig. 1A ) in response to varying concentrations of OT. In the absence of DAergic inhibition, unstimulated cells (C; Fig. 1A ) secreted PRL at 35.4 Ϯ 2.7% of the maximal TRH response (10 Ϫ6 m) (mean Ϯ sem, n ϭ 12 coverslips). The application of 10 Ϫ8 m OT led to a significant (P Ͻ 0.01) increase in PRL secretion to 72.7 Ϯ 8.8% (n ϭ 4 coverslips) of the TRH response. Secretion peaked with the application of 10 Ϫ7 m OT (91.7 Ϯ 10.6%, P Ͻ 0.01, n ϭ 3 coverslips). A higher dose of OT (10 Ϫ6 m) yielded a smaller PRL secretory response (59.3 Ϯ 7.6%, n ϭ 5 coverslips) that was still significantly greater (P Ͻ 0.05) than the control value.
The [Ca 2ϩ ] i response to OT application (10 Ϫ8 -10 Ϫ6 m) was Initial values for DA, OT, and PRL were set to DA(0) ϭ 20,000 ng/ml; OT(0) ϭ 25 pg/ml; and PRL(0) ϭ 20 ng/ml. Ϫ7 m OT. The peak level of 24.3 Ϯ 11.3 ng/ml secreted PRL was significantly (P Ͻ 0.05) higher than basal levels of 6.8 Ϯ 0.9 ng/ml (n ϭ 3 coverslips).
Neurosecretory OT neurons in the PVN and periventricular nucleus (PeVN) express VIP receptor
The retrogradely transported neurotracer FG (iv injected) in combination with ICC was used to identify neurosecretory OT cells. In addition, ICC was performed to determine the pattern of VIP2R expression in neurosecretory OT cells.
Anatomical analysis of OT-FG double staining showed colocalization of a majority of the OT neurons in the anterior magnocellular portion of the PVN (close to the ventral border of the fornix) and the PeVN (yellow staining in Fig. 2A ). Similar strong OT-FG colocalization was found further caudal in the lateral and ventral portion of the PVN (yellow staining in Fig. 2B ). The localization of OT neurons expressing VIP2R overlapped with OT-FG labeling, especially in the PeVN (filled arrowheads in Fig. 2C ) and in the magnocellular portion of the PVN (filled arrowheads in Fig. 2D ). Overlap in these two regions was more extensive than in the other portions of the PVN, where colocalization appeared in only a few scattered cells.
VIP AS oligonucleotide injection into SCN changes the pattern of PRL and OT secretion in CS rats
AS-ODN technique was used to determine the influence of VIP (of SCN origin) in the regulation of OT release and PRL secretion. The reduction of VIP expression caused by the injection of VIP AS-ODN was quantified by analysis of the mean pixel intensity of ICC VIP staining on SCN sections. In the same sections, proper cannula placement was verified (cannulae tip above the dorsal border of the SCN).
The experiments with ODN were performed using the same procedure as described previously (24) . AS-ODN against VIP mRNA injected into the SCN caused an ablation of the D PRL surge and a shift of the afternoon OT surge. The remaining surges for both PRL (99.8 Ϯ 34.2 ng/ml, mean Ϯ sem, n ϭ 4; Fig. 3A , open circles) and OT (317.5 Ϯ 128.5 pg/ml, n ϭ 5; Fig. 3B , open circles) peaked simultaneously at 0300 h. Serum PRL measurements from CS-OVX rats, which received RS-ODN injection (as control) confirmed the wellknown PRL secretory pattern of two peaks per day (N and D surges; Fig. 3A, filled circles) . The serum concentration of PRL peaked at 0300 h (61.9 Ϯ 37.6 ng/ml, n ϭ 5) and at 1700 h (41.8 Ϯ 8.5 ng/ml, n ϭ 4). The concentration of OT in serum increased in the afternoon, with a peak value of 432.5 Ϯ 161.4 pg/ml (n ϭ 5) at 1300 h (Fig. 3B, filled circles) . Additional control studies were performed on CS-OVX rats without SCN cannula. Blood serum analysis from these experiments demonstrated the same secretory pattern of PRL and OT to that of RS-ODN injected CS-OVX rats (data not shown).
The effect of VIP AS-ODN administration on VIP synthesis in the SCN is shown in Fig. 4 . Compared with the control sections, the injection of the AS-ODN caused a significant reduction (P Ͻ 0.05) in VIP immunoreactivity (presented as pixel intensity). Figure 4A shows a photomicrograph of a representative SCN section of animals treated with VIP AS-ODN, 58 h after the ODN injection. The dashed circles in 4A demonstrate the position and the area used for the calculation of the mean pixel intensity, encompassing the core region of SCN on both sides of the third ventricle (III). In addition, the * in Fig. 4A indicates the placement of the former tip of the implanted bilateral cannulae. SCN brain sections of untreated animals (Fig. 4B ) displayed a more intense VIP immunoreactivity. Figure 4C shows a bar graph of the mean pixel intensity calculated for four control animals, three VIP AS-ODNtreated animals, and three RS-ODN-treated animals. The readings revealed a reduction from 202.5 Ϯ 3.1 (mean intensity value Ϯ sem) for the controls down to 174.2 Ϯ 11.2 in VIP AS-ODN-treated animals (Fig 4C) . In contrast, the injection of RS-ODN did not affect VIP synthesis. The mean pixel intensity remained high at 199.9 Ϯ 2.9 (n ϭ 3 animals).
Mathematical model of the proposed PRL secretion mechanism
To help interpret the data from this study, we have developed a mathematical model. This provides the means to illustrate our hypothesis of how the different cell populations interact together to produce the rhythmic PRL secretion shown in Fig. 3 .
The model components are illustrated in Fig. 5 . Experimental data suggest that VIPergic neurons from the SCN provide rhythmic inhibitory input to DA neurons of the arcuate nucleus (24) and to OT neurons of the PVN/PeVN (Fig. 2, C and D; and Refs. 14 and 15). The DA neurons exert sustained inhibitory input to lactotrophs (2), whereas OT neurons impose stimulatory input (Fig. 1) . In addition, there are data suggesting that OT neurons in the PVN receive rhythmic stimulatory input (11), represented as factor x in the model. The pathways illustrated in Fig. 5 are incorporated into the mathematical model, which includes time-dependent equations for PRL, DA, and OT concentrations. The model contains what we postulate to be the main components controlling rhythmic PRL secretion in CS rats. For simplicity, other interactions, such as PRL feedback onto DAergic neurons (38, 39) , have not been included in this preliminary model. Figure 6 shows simulations for CS-OVX animals. The N surge of PRL (0300 h, Fig. 6A ) is due to a decrease in the DA tone (Fig. 6B) , which is caused by the high nighttime level of VIP (Fig. 6C ). This elevated VIP activity inhibits the activity of DA neurons, thus eliminating the inhibitory input to the lactotrophs. The OT neurons play little role in the N PRL surge because their activity is also inhibited by the elevated VIPergic input (Fig. 6B) . In the afternoon, the VIPergic input to DA and OT neurons is greatly reduced (Fig. 6C) . As a result, the DA tone is greater in the afternoon, providing inhibitory input to the lactotrophs (Fig. 6B) . However, there is an afternoon increase in the activity of OT neurons due to drive from a stimulatory x-factor and no inhibitory VIP input (Fig. 6, B and C) . This leads to the D surge of PRL. Because of the higher DA tone at this time of the day, the peak PRL level does not reach the N values (Fig. 6A) . The identity of the x-factor is unknown at this time, although there is evidence that serotonin plays this role (8, 11) .
Discussion
Data from this study elucidate the role that OT and VIP play in regulating PRL secretion of rats stimulated in the uterine cervix. Factors other than OT and VIP may be more important in controlling estrogen-or suckling-induced PRL surges. It is indeed possible that VIP is but one member of a family of neurotransmitters originating in the SCN that regulates PRL secretion via inhibitor and stimulator factors such as DA and OT, which differ in various physiological states.
Results from the Ca 2ϩ imaging experiments in combination with measurements of PRL highlighted the ability of OT to induce PRL secretion from lactotrophs in a dose-dependent manner. These experiments demonstrated simulta- A, Only nocturnal PRL surges were measured in the serum of VIP AS-ODN-treated animals (outlined circles, n ϭ 4) in contrast to the typical nocturnal and diurnal PRL surges in control animals (filled circles, n ϭ 5). B, Instead of a prominent afternoon OT surge like in the control animals (filled circles, n ϭ 5) there was a nocturnal secretory OT peak coincident with the PRL peak (outlined circles, n ϭ 5). Values are expressed as mean Ϯ SEM nanograms per milliliter of PRL, mean Ϯ SEM picograms per milliliter of OT. *, Significant differences compared with RS-ODN (P Ͻ 0.05).
neous elevation of [Ca 2ϩ ] i and a PRL surge in response to OT application. Therefore, our findings bridge the results from studies demonstrating the pivotal role of [Ca 2ϩ ] i changes in the regulation of PRL secretion from lactotrophs (37) and the secretion of PRL in a dose-dependent fashion during OT treatment of dispersed anterior pituitary cells from lactating rats (40) . The biphasic change in the [Ca 2ϩ ] i response after OT treatment indicates an initial depletion of intracellular Ca 2ϩ stores followed by the opening of Ca 2ϩ channels (41, 42) . Further experiments need to be done to clarify the mechanism of this biphasic [Ca 2ϩ ] i change. The fact that 31% of the cells (lactotroph-enriched cell population) responded to OT with enhanced [Ca 2ϩ ] i emphasizes the well-known heterogeneity in the response of lactotrophs to secretagogues (43) .
The results from the ICC experiments using OT and VIP2R antibodies in combination with FG suggests that VIP controls neurosecretory OT cells. The neurosecretory nature of OTergic cells in the PeVN and PVN was clearly demonstrated by the colocalization of FG (retrogradely transported neurotracer, iv applied) and OT immunostaining. Neuronal tracing studies have proven that the median eminence receives fibers from parvocellular and magnocellular OT neurons in the PVN (44) and from neurosecretory cells located in the PeVN (45) . Therefore, release of OT from these PeVN and PVN neurons may occur in the median eminence. From there, OT could be further transported to the anterior pituitary gland via the long portal vessels. The pituitary portal vascular system has been proposed to be a window for the central OT neurotransmission to pituitary lactotrophs (44, 46) . Alternatively, our detection of OT in the peripheral blood could reflect an overflow from magnocellular cells comprising the hypothalamo-hypophyseal tract to the sinusoids in the posterior lobe and thus could be the route through which OT reaches the anterior pituitary or reflect the delivery through the short portal vessels. Because our results do not distinguish between a magnocellular or parvocellular origin of OT reaching the lactotrophs, additional investigations are needed to further clarify which of the different subpopulations of neurosecretory OT cells in the PVN and PeVN are responsible for the OT stimulation of lactotrophs in CS rats.
Because PRL surges in CS rats appear in two narrow time windows every day and seem to be light entrained (47, 48) , it is likely that these events are triggered by mechanisms involving the light-sensing SCN. VIP synthesis in the SCN is mainly regulated by lighting conditions, causing daily fluctuation (17) (18) (19) . Because PIH and PRH regulate PRL secretion from lactotrophs in the anterior pituitary gland, it is presumed that the SCN controls these two offsetting factors to govern the PRL surges. VIP would therefore relay time-ofday information to DA neurons as well as OT neurons. Gerhold et al. (24, 26) demonstrated that VIP from the SCN relays time-of-day information to neuroendocrine DAergic neurons 6 . PRL, OT, and DA secretion patterns for CS-OVX rats simulated by the mathematical model. The amount of secreted PRL (A) depends on the input of stimulatory OT (B) and inhibitory DA (B) at any given time. Timing of surges is controlled by the trigger factors VIP and x-factor, which provide input to OT and DA neurons (C). The first PRL surge is primarily due to reduction in the inhibitory DA tone, whereas the second is mainly due to stimulation from OT neurons. The values for OT, DA, VIP, and the x-factor have been normalized to their peak values.
by inhibiting the release of the important PIH DA. Although we did not verify a direct connection of VIPergic neurons from the SCN to neurosecretory OT cells, it is reasonable to assume such a link based on our ICC experiments demonstrating VIP2R immunoreactivity on FG-labeled OT neurons. Furthermore, neuronal connection from SCN to the PVN has also been described using different tract-tracing techniques (14, 15) . Buijs et al. (49) revealed VIP-containing SCN efferents traveling along the wall of the third ventricle to the PVN. In addition, the authors argued that the rostral PVN, the periventricular PVN and the dorsomedial hypothalamus are excellent candidates for SCN-PVN interactions.
Assuming that VIP controls the activity of DA and OT neurons, an interruption of VIP synthesis in the SCN should consequently alter the PRL release pattern. Indeed, our VIP AS-ODN experiments confirmed such a relationship by demonstrating changes in the timing of PRL and OT surges.
The PRL and OT secretory pattern shown in Fig. 3 can be explained by assuming that VIP exerts an inhibitory influence on OTergic and DAergic neurons. Elevated VIP mRNA and peptide content in the SCN at night could indicate an increased VIPergic signaling to target areas (18) , including PVN, PeVN, and arcuate nucleus. Studies in which the VIP content in PVN was determined, revealed a higher content between 2200 h and 0600 h than during the rest of the day (11). However, further experiments are necessary to define the daily release pattern of VIP at the terminals. The enhanced inhibitory input to the DA and OT neurons consequently decrease their activity. As a result, the reduced DA tone would initiate the nocturnal PRL surge. At this time, the activity of the OT neurons would be damped through inhibition by VIP. During the day, there would be less inhibition of the DA and OT neurons due to the low VIP expression in the SCN. An additional trigger signal is needed to induce the release of OT that would initiate the D PRL surge. Serotonin may represent such a trigger (factor x), based on earlier data for its involvement in the regulation of the D PRL surge in CS-OVX rats (8) . Because there is less inhibition of DA neurons by VIP in the afternoon, the OT-induced afternoon PRL surge would be smaller than the morning surge (50) . To test our hypothesis, further experiments need to be done to clarify the secretory pattern of VIP as well as 5-HT at these OT and DA neurons.
The injection of VIP AS-ODN into the SCN-dampened VIP synthesis (24) . According to the notion that VIP exerts an inhibitory influence on DAergic and OTergic neurons, inhibition of both types of neurosecretory cells would be reduced by the AS-ODN treatment. The fact that we could still measure morning OT and PRL surges in these CS rats supports the idea of the existence of a rhythmic VIP-independent x-factor that stimulates OT neurons initiating the PRL surge. In contrast, the lack of the afternoon surges of OT and PRL indicates a VIP dependence of SCN origin. Because there would be no VIP inhibition to OT neurons in the VIP AS-ODN-treated animals in the morning, the stimulatory input to the OT neurons by the x-factor could produce an OT and thus PRL surge. However, the VIP dependence of the afternoon x-factor would make it impossible to generate a stimulatory input in VIP AS-ODN-treated animals. Therefore, we could only measure morning OT and PRL surges.
The results of the ODN experiments suggest that VIP is not the only SCN transmitter signal controlling the PRL surges in CS rats. The remaining question is whether other SCN neurochemicals like arginine vasopressin are directly or indirectly involved in forming the morning x-factor stimulus. This non-VIP-dependent stimulatory input could also account for the remaining PRL surges in CS rats held in constant dark (47) . Further experimental studies are required to verify this hypothesis.
Mathematical modeling was used to illustrate our hypothesis of how VIP of SCN origin can serve as a timing signal to control DAergic and OTergic neurosecretory cells, which in turn controls PRL secretion from lactotrophs. In our model, the N PRL surge in CS-OVX animals is due primarily to decreased DA tone, whereas the D PRL surge is due to pronounced OT stimulation. The model simulations demonstrate that the proposed interactions within this small network might be responsible for the regulation of rhythmic PRL secretion in CS-OVX rats.
Whereas the mathematical model illustrates the self-consistency of our hypothesis for rhythmic PRL secretion, it in no way proves that other processes are not involved. Also, model parameters where chosen to illustrate our hypothesis, and were not independently calibrated. Despite these caveats, the model has provided an important prediction, that daily stimulatory input (x-factor) is provided to OT neurons. Clarification of the source of this stimulatory factor is a target of future work.
In summary, our results suggest that OT is a potent PRH that stimulates lactotrophs via Ca 2ϩ -dependent mechanisms. Furthermore, neurosecretory OT cells in the PVN and PeVN showed VIP2R expression. The injection of VIP AS-ODN into the SCN caused an alteration in the OT and PRL secretory rhythms of CS-OVX rats, which indicates that VIP of SCN origin could control the activity of neurosecretory OT cells in the PeVN and the PVN. Therefore, light-entrained VIP from the SCN may relay time-of-day information to neurosecretory OT cells in the PeVN and the PVN, triggering PRL secretion from lactotrophs in the anterior pituitary gland.
